Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS-Asia

被引：0
|
作者：
Yang, M. [1 ]
Ji, L. [2 ]
Liu, Y. [3 ]
Miao, H. [4 ]
Xie, Y. [5 ]
Wang, W. [1 ]
Mu, Y. [1 ]
Yan, P. [1 ,6 ]
Pan, S.
Lauring, B. [7 ]
Liu, S. [8 ]
Huyck, S. [7 ]
Wang, D. [8 ]
Terra, S. G. [9 ]
机构：
[1] Pfizer China R&D Co, Shanghai, Peoples R China
[2] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[3] Yancheng First Peoples Hosp, Yancheng, Peoples R China
[4] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China
[5] Pingxiang Peoples Hosp, Pingxiang, Peoples R China
[6] Pfizer Inc, New York, NY USA
[7] Merck & Co Inc, Kenilworth, NJ USA
[8] Merck & Co Inc, Beijing, Peoples R China
[9] Pfizer Inc, Andover, MA USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
633
引用
收藏
页码：S307 / S308
页数：2
相关论文
共 50 条
  • [31] Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET)
    Rosenstock, Julio
    Frias, Juan
    Pall, Denes
    Charbonnel, Bernard
    Pascu, Raluca
    Saur, Didier
    Darekar, Amanda
    Huyck, Susan
    Shi, Harry
    Lauring, Brett
    Terra, Steven G.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 520 - 529
  • [32] EFFICACY AND SAFETY OF ANAGLIPTIN COMPARED WITH SITAGLIPTIN AS AN ADD-ON FOR PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
    Jin, S. -M.
    Park, S. W.
    Yoon, K. -H.
    Lee, M. -K.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S135 - S136
  • [33] Efficacy and safety of saxagliptin and glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy: results from the SPECIFY study
    Gu, T.
    Zhu, L.
    Niu, Q.
    Li, C.
    Bi, Y.
    Zhu, D.
    [J]. DIABETOLOGIA, 2018, 61 : S379 - S379
  • [34] A phase 3 trial to evaluate the efficacy and safety of chiglitazar added to metformin in Chinese patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Gao, L.
    Ji, L.
    Dong, X.
    Cheng, Z.
    Zhang, X.
    Sun, W.
    Ma, J.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S359 - S360
  • [35] Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy
    Bailey, C. J.
    Gross, J. L.
    Yadav, M.
    Iqbal, N.
    Mansfield, T. A.
    List, J. F.
    [J]. DIABETOLOGIA, 2011, 54 : S67 - S67
  • [36] Efficacy and safety of alogliptin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise
    Mekki, Q.
    Fleck, P.
    Wilson, C.
    DeFronzo, R.
    [J]. DIABETOLOGIA, 2008, 51 : S344 - S344
  • [37] Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone
    Terra, Steven G.
    Focht, Kristen
    Davies, Melanie
    Frias, Juan
    Derosa, Giuseppe
    Darekar, Amanda
    Golm, Gregory
    Johnson, Jeremy
    Saur, Didier
    Lauring, Brett
    Dagogo-Jack, Sam
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 721 - 728
  • [38] Efficacy of glyburide/metformin tablets versus metformin plus rosiglitazone in patients with Type 2 diabetes inadequately controlled with metformin monotherapy.
    Mohideen, P
    Klein, E
    Bruce, S
    [J]. DIABETOLOGIA, 2002, 45 : A242 - A242
  • [39] Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study
    Aronson, Ronnie
    Frias, Juan
    Goldman, Allison
    Darekar, Amanda
    Lauring, Brett
    Terra, Steven G.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (06): : 1453 - 1460
  • [40] Efficacy and safety of dapaglflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise
    Kaku, K.
    Kiyosue, A.
    Inoue, S.
    Ueda, N.
    Tokudome, T.
    Yang, J.
    Langkilde, A. M.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (11): : 1102 - 1110
12345